Showing results (1381-1390 of 1,406) with videos related to

Sort By:
Pageof 141
Neuron|April 23, 2024
Growth hormone promotes myelin repair after chronic hypoxia via triggering pericyte-dependent angiogenesisShu-Yu Ren, Yu Xia, Bin Yu, et al.
Virology Journal|October 30, 2016
HBsAg and HBeAg in the prediction of a clinical response to peginterferon α-2b therapy in Chinese HBeAg-positive patientsSong Yang, Huichun Xing, Yuming Wang, et al.
NEJM Evidence|February 6, 2024
Zilovertamab Vedotin Targeting of ROR1 as Therapy for Lymphoid CancersMichael L Wang, Jacqueline C Barrientos, Richard R Furman, et al.
Journal of Clinical Virology : the Official Publication of the Pan American Society for Clinical Virology|September 10, 2014
Peginterferon alfa-2b in the treatment of Chinese patients with HBeAg-positive chronic hepatitis B: a randomized trialJun Cheng, Yuming Wang, Jinlin Hou, et al.
Clinical and Molecular Hepatology|January 22, 2025
Update on the treatment navigation for functional cure of chronic hepatitis B: Expert consensus 2.0Di Wu, Jia-Horng Kao, Teerha Piratvisuth, et al.
Science Bulletin|January 19, 2024
Dominant contribution of combustion-related ammonium during haze pollution in BeijingLibin Wu, Peng Wang, Qiang Zhang, et al.
The Lancet. Oncology|November 27, 2025
Camrelizumab plus rivoceranib versus sorafenib as first-line therapy for unresectable hepatocellular carcinoma (CARES-310): final analysis of a randomised, open-label, international, phase 3 studyShukui Qin, Shanzhi Gu, Stephen L Chan, et al.
The Journal of Dermatological Treatment|July 15, 2026
Stapokibart reduces blood eosinophil counts in patients with moderate-to-severe atopic dermatitis: a post-hoc analysis from phase II and phase III clinical trialsYan Zhao, Furen Zhang, Bin Yang, et al.
Journal of Cancer Research and Therapeutics|October 7, 2022
Chinese expert consensus on the nursing management of the totally implantable venous access deviceYin Xu, Xiao-Yan Fei, You-Hua Xue, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|February 2, 2022
Safety and antibody response to inactivated COVID-19 vaccine in patients with chronic hepatitis B virus infectionTaiyu He, Yingzhi Zhou, Pan Xu, et al.
Pageof 141